Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_assertion type Assertion NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_head.
- NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_assertion description "[The findings of kinase switching and acquired PDGFR and FGFR signaling suggest investigation of new inhibitor combinations to target NSCLC metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_provenance.
- NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_assertion evidence source_evidence_literature NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_provenance.
- NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_assertion SIO_000772 18696232 NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_provenance.
- NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_assertion wasDerivedFrom befree-20140225 NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_provenance.
- NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_assertion wasGeneratedBy ECO_0000203 NP413036.RAz8X-N56eoelZfqhRqWq6ED-Y7PjI_ITfVBKQ0VdncE8130_provenance.